A comparison of outcomes from a regional Mesothelioma MDT against the National Lung Cancer Audit (NLCA) Mesothelioma standards
M. Ahmed (Manchester, United Kingdom), J. Lyons (Manchester, United Kingdom), S. Jackson (Manchester, United Kingdom), A. Sharman (Manchester, United Kingdom), M. Dixon (Manchester, United Kingdom), P. Taylor (Manchester, United Kingdom), J. Holme (Manchester, United Kingdom), M. Evison (Manchester, United Kingdom)
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Ahmed (Manchester, United Kingdom), J. Lyons (Manchester, United Kingdom), S. Jackson (Manchester, United Kingdom), A. Sharman (Manchester, United Kingdom), M. Dixon (Manchester, United Kingdom), P. Taylor (Manchester, United Kingdom), J. Holme (Manchester, United Kingdom), M. Evison (Manchester, United Kingdom). A comparison of outcomes from a regional Mesothelioma MDT against the National Lung Cancer Audit (NLCA) Mesothelioma standards. 2889
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: